The Baroque Artists of Champaign-Urbana will offer the holiday music program “A German Baroque Christmas” at 7:30 p.m. Dec. 13 at Holy Cross Catholic Church, 405 W. Clark St., Champaign. The program includes the University High School Madrigals and the Baroque Artists of Champaign-Urbana chorus and orchestra, featuring J. S. Bach’s popular Brandenburg Concerto No. 2 with guest trumpeter Aaron Romm; the spectacular Christmas cantata, “Christians, Engrave This Day”; and hymns and carols with audience participation. Tickets are $20 for general admission and $10 for students. Ten percent of door proceeds will be donated to the Eastern Illinois Foodbank. Tickets can be purchased in advance online.
Read Next
Twelve Illinois scientists rank among the world’s most influential
CHAMPAIGN, Ill. — Twelve scientists at the University of Illinois Urbana-Champaign have been named to the 2025 Clarivate Analytics Highly Cited Researchers list. The list recognizes researchers and social scientists who have demonstrated exceptional influence, as reflected through their publication of multiple papers frequently cited by their peers during the last decade. The highly cited […]
Study shows new hope for commercially attractive lithium extraction from spent batteries
A new study shows that lithium — a critical element used in rechargeable batteries and susceptible to supply chain disruption — can be recovered from battery waste using an electrochemically driven recovery process. The method has been tested on commonly used types of lithium-containing batteries and demonstrates economic viability with the potential to simplify operations, minimize costs and increase the sustainability and attractiveness of the recovery process for commercial use.
Study: A cellular protein, FGD3, boosts breast cancer chemotherapy, immunotherapy
CHAMPAIGN, Ill. — A naturally occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of some anticancer agents, including doxorubicin, one of the most widely used chemotherapies, and a preclinical drug known as ErSO, researchers report. The protein, FGD3, contributes to the rupture of cancer cells disrupted […]